Kymera Therapeutics (KYMR) EPS (Diluted) (2020 - 2026)

Kymera Therapeutics (KYMR) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.75
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.52
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Kymera Therapeutics 10.77 Bn 10.12 Bn - -0.71

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.71
Dec 31, 2025 -1.03
Sep 30, 2025 -0.94
Jun 30, 2025 -0.95
Mar 31, 2025 -0.82
Dec 31, 2024 -0.94
Sep 30, 2024 -0.82
Jun 30, 2024 -0.58
Mar 31, 2024 -0.69
Dec 31, 2023 -0.25
Sep 30, 2023 -0.90
Jun 30, 2023 -0.67
Mar 31, 2023 -0.70
Dec 31, 2022 -0.65
Sep 30, 2022 -0.79
Jun 30, 2022 -0.78
Mar 31, 2022 -3.26
Dec 31, 2021 -0.71
Sep 30, 2021 -5.33
Jun 30, 2021 -0.55